RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

FHS
May 15, 2024
7:06 pm

A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases.

OMNY Health Launches GLP-1 Data Network for Research

What You Should Know: – OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network. – The

August 27, 2024

Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch

Good morning, everyone, and nice to see you again after an extended holiday break, at least for many on this side of the pond. We

July 5, 2023

Updated: NIH says SIGA’s antiviral didn’t improve resolution in mpox lesions in the DRC

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.